logo
Cannabis Linked to 2x Risk of Heart Disease Death, Scientists Discover

Cannabis Linked to 2x Risk of Heart Disease Death, Scientists Discover

Yahoo22-06-2025
New research suggests that cannabis use is linked to twice the risk of death from cardiovascular disease, and is also associated with increased risk of other major adverse cardiovascular events (MACE).
Cannabis is being legalized in more and more places worldwide, increasing medicinal and recreational use – but it may warrant closer monitoring by health professionals. The researchers here, led by a team from the University of Toulouse in France, wanted to look more closely at potential health risks that had previously been flagged.
They looked at 24 previous studies published between 2016 and 2023, involving around 200 million people. Overall, the increased risk linked to cannabis use was 29 percent for acute coronary syndrome (reduced blood flow to the heart), 20 percent for strokes, and 100 percent for cardiovascular disease mortality.
"The findings reveal positive associations between cannabis use and MACE," write the researchers in their published paper. "These findings should encourage investigating cannabis use in all patients presenting with serious cardiovascular disorders."
There are some limitations worth bearing in mind here. The studies included in the research differed in terms of how they defined cannabis use, relied on self-reporting, and didn't measure use of the drug over time. That makes them less statistically robust.
The research also notes a high risk of bias in the majority of studies investigated, due to the way they were structured.
And it's important to say the research doesn't show direct cause and effect, only an association. It's possible that other factors not considered here are driving both cannabis use and heart health issues in certain groups of people.
Nevertheless, the large number of people surveyed on their real-world use of cannabis counts in the study's favor. It also has more recent data than many other studies, and we know that cannabis use and composition is changing over time.
That's enough to warrant deeper investigation into the possible health risks.
"Legalizing the drug and expanding its medical use worldwide have likely contributed to profound changes in the general perception of cannabis and to the overall rise in cannabis consumption," write the researchers.
"Consequently, users' profiles and consumption habits profoundly differ from those in the 2010s, especially as cannabis products show an increasing trend in potency, with rising concentrations of delta-9-tetrahydrocannabinol (THC)."
Further research is absolutely needed here, not least to determine whether the chemicals and compounds in cannabis – of which there are hundreds – could be leading to these health risks, and how taking cannabis in different forms, such as inhalables or edibles, might have an influence.
Previous studies have already shown how the drug can increase the risk of cancer, and significantly alter our DNA, for example. Cannabis could also trigger psychosis through the impact it has on the brain.
The new study is accompanied by an editorial written by epidemiologists Stanton Glanz and Lynn Silver, from the University of California San Francisco. In it, Glanz and Silver argue that as cannabis use rises, more should be done to educate people about the risks – as has been done with cigarettes.
"Specifically, cannabis should be treated like tobacco: not criminalized but discouraged, with protection of bystanders from secondhand exposure," they write.
The research has been published in the journal Heart.
5 Daily Habits Could Be Causing Your Liver Serious Harm
FDA-Approved Sleeping Pill Slows Alzheimer's Tangles in Pre-Clinical Trial
Risk of Sleep Breathing Disorder Set to Rise 45% by End of Century
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New study finds coffee is good for you, but there's a catch
New study finds coffee is good for you, but there's a catch

Fast Company

timean hour ago

  • Fast Company

New study finds coffee is good for you, but there's a catch

Coffee drinking has been studied for decades as researchers have aimed to answer one burning question: Is it good for you? Or is it better to stick to joyless drinks like, you know, tap water and mint tea? While there have been cases for just about every argument, one recently published study in The Journal of Nutrition just added another check in the 'healthy' column. Of course, there's a catch. You have to drink your coffee in a specific way. For the study, researchers at Tufts University analyzed the coffee-drinking habits of 46,332 Americans from 1999 to 2018. They found that drinking a cup of coffee each day has some major effects in terms of lowering mortality rates. One cup of joe per day was linked to a 16% lower risk of death, not just related to cardiovascular disease, which has been well-documented, but from any cause. More coffee is better, too—but not too much more. Drinking two to three cups per day showed a 17% lower risk of mortality. More coffee than that didn't offer any additional health benefits. However, these benefits didn't apply to all coffee drinkers across the board. The benefits were most pronounced in those who drank theirs sans cream and sugar (or with a very little amount of sugar). The ones who added cream and sugar had the same rates of all-cause mortality as those who tended toward non-coffee drinks. Essentially, the more cream and sugar added, the lower the benefits. 'Coffee is among the most-consumed beverages in the world, and with nearly half of American adults reporting drinking at least one cup per day, it's important for us to know what it might mean for health,' said Fang Fang Zhang, senior author of the study and a professor at Tufts. 'The health benefits of coffee might be attributable to its bioactive compounds, but our results suggest that the addition of sugar and saturated fat may reduce the mortality benefits.' Given that there is so much research around coffee, we always have to take findings with a grain of salt (and sans sweetener), but the good news does seem to be adding up for regular coffee drinkers. A study earlier this year similarly found lower rates of premature death for morning coffee drinkers. Another published in June 2025 found that coffee drinking is linked to healthy aging, particularly in women.

BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform
BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform

Yahoo

time4 hours ago

  • Yahoo

BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform

Novo Nordisk A/S (NYSE:NVO) is one of the top cheap stocks that will go to the moon according to Reddit. On August 13, BNP Paribas Exane upgraded Novo Nordisk A/S (NYSE:NVO) to Neutral from Underperform with a $54 price target. An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. The firm told investors that it sees a more balanced risk/reward now that the company's 'reality' is better reflected in the shares. Novo Nordisk A/S (NYSE:NVO) announced results for the January 1 to June 30 period on August 6, reporting an operating profit growth of 25% in Danish kroner and 29% at constant exchange rates (CER) to DKK 72.2 billion. Management also stated that sales in US Operations rose by 16% in Danish kroner (17% at CER), while sales in International Operations grew by 16% in Danish kroner (19% at CER). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products. While we acknowledge the potential of XXXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store